Details for Patent: 11,576,894
✉ Email this page to a colleague
Which drugs does patent 11,576,894 protect, and when does it expire?
Patent 11,576,894 protects INVOKAMET and is included in one NDA.
This patent has fifty patent family members in thirty-nine countries.
Drugs Protected by US Patent 11,576,894
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Pharms | INVOKAMET | canagliflozin; metformin hydrochloride | TABLET;ORAL | 204353-001 | Aug 8, 2014 | RX | Yes | No | 11,576,894 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Janssen Pharms | INVOKAMET | canagliflozin; metformin hydrochloride | TABLET;ORAL | 204353-002 | Aug 8, 2014 | RX | Yes | No | 11,576,894 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Janssen Pharms | INVOKAMET | canagliflozin; metformin hydrochloride | TABLET;ORAL | 204353-003 | Aug 8, 2014 | RX | Yes | No | 11,576,894 | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,576,894
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 077464 | ⤷ Subscribe | |||
| Argentina | 118805 | ⤷ Subscribe | |||
| Australia | 2010270669 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
